Kidney dysfunction: prevalence and associated risk factors in a community-based study from the North West Province of South Africa

Nonkululeko Hellen Navise, Gontse Gratitude Mokwatsi, Lebo Francina Gafane-Matemane, June Fabian, Leandi Lammertyn, Nonkululeko Hellen Navise, Gontse Gratitude Mokwatsi, Lebo Francina Gafane-Matemane, June Fabian, Leandi Lammertyn

Abstract

Background: Globally, the World Health Organization ranks chronic kidney disease (CKD) as one of the top 10 causes of mortality. In South Africa, where noncommunicable diseases have become leading causes of mortality, the true population prevalence of CKD is unknown and associated risk factors remain understudied. This study aimed to describe the prevalence of kidney dysfunction and associated risk factors in a community from the North West province of South Africa.

Methods: This cross-sectional study included 1999 participants older than 30 years. Kidney dysfunction was defined as (i) estimated glomerular filtration rate (eGFR) < 90 ml/min/1.73m2, or (ii) urine albuminuria-to-creatinine ratio (uACR) ≥ 3.0 mg/mmol, or a combination (i and ii). Risk factors included age, sex, urban/rural locality, body mass index (BMI), blood pressure (BP), lipid profile, haemoglobin A1c (HbA1C), C-reactive protein (CRP), gamma-glutamyl transferase (GGT), tobacco use, and HIV status.

Results: Mean age of participants was 48 (42;56) years, and 655/1999 (33%) had eGFR < 90 ml/min/1.73m2 and/or uACR ≥ 3.0 mg/mmol. Compared to those with normal kidney function, participants with eGFR < 90 ml/min/1.73m2 and/or uACR ≥ 3.0 mg/mmol were older, female, had higher measures of adiposity, systolic, diastolic, and mean arterial blood pressure, serum lipids and C-reactive protein (CRP) (all p ≤ 0.024). In multiple regression analyses eGFR was associated with systolic BP (β = 0.11) and HIV infection (β = -0.09), and albuminuria was associated with elevated CRP (β = 0.12) and HIV infection (β = 0.11) (all p < 0.026). In both groups (individuals with and without kidney dysfunction respectively), eGFR was associated with age (β = -0.29, β = -0.49), male sex (β = 0.35, β = 0.28), BMI (β = -0.12, β = -0.09), low-density/high-density lipoprotein cholesterol ratio (β = -0.17, β = -0.09) and CRP (β = 0.10, β = 0.09) (all p < 0.005); and uACR was associated with female sex (β = 0.10, β = -0.14), urban locality (β = -0.11, β = -0.08), BMI (β = -0.11, β-0.11), and systolic BP (β = 0.27, β = 0.14) (all p < 0.017).

Conclusion: In this study from the North West province, South Africa, eGFR < 90 ml/min/1.73m2 and/or uACR ≥ 3.0 mg/mmol was prevalent and associated with modifiable risk factors. The findings may inform screening strategies for kidney disease prevention, focusing on women, obesity, blood pressure control, dyslipidaemia, identifying and treating inflammation, and HIV diagnosis and treatment.

Keywords: C-reactive protein; HIV infection; Kidney dysfunction; Prevalence; Risk factors; Systolic blood pressure.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2023. The Author(s).

References

    1. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–70. doi: 10.1038/ki.2011.368.
    1. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - A systematic review and Meta-analysis. PLoS One. 2016 doi: 10.1371/journal.pone.0158765.
    1. Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, et al. The epidemiology of chronic kidney disease in sub-saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174–81. doi: 10.1016/S2214-109X(14)70002-6.
    1. Mills KT, Xu Y, Zhang W, Bundy JD, Chen C-S, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–7. doi: 10.1038/ki.2015.230.
    1. Sumaili EK, Krzesinski J-M, Zinga CV, Cohen EP, Delanaye P, Munyanga SM, et al. Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009;24(1):117–22. doi: 10.1093/ndt/gfn469.
    1. Arogundade FA, Barsoum RS. CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis. 2008;51(3):515–23. doi: 10.1053/j.ajkd.2007.12.006.
    1. George JA, Brandenburg J-T, Fabian J, Crowther NJ, Agongo G, Alberts M, et al. Kidney damage and associated risk factors in rural and urban sub-saharan Africa (AWI-Gen): a cross-sectional population study. Lancet Global Health. 2019;7(12):e1632–e43. doi: 10.1016/S2214-109X(19)30443-7.
    1. Peer N, George J, Lombard C, Steyn K, Levitt N, Kengne A-P. Prevalence, concordance and associations of chronic kidney disease by five estimators in South Africa. BMC Nephrol. 2020 doi: 10.1186/s12882-020-02018-x.
    1. Matsha TE, Yako YY, Rensburg MA, Hassan MS, Kengne AP, Erasmus RT. Chronic kidney diseases in mixed ancestry south african populations: prevalence, determinants and concordance between kidney function estimators. BMC Nephrol. 2013 doi: 10.1186/1471-2369-14-75.
    1. Moosa M, Van der Walt I, Naicker S, Meyers AJSAMJ. Important causes of chronic kidney disease in South Africa. S Afr Med J. 2015;105(4):320–7. doi: 10.7196/SAMJ.9535.
    1. Kabudula CW, Houle B, Collinson MA, Kahn K, Gómez-Olivé FX, Clark SJ, et al. Progression of the epidemiological transition in a rural south african setting: findings from population surveillance in Agincourt, 1993–2013. BMC Public Health. 2017 doi: 10.1186/s12889-017-4312-x.
    1. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009 doi: 10.1016/j.ahj.2009.04.019.
    1. Keyes CL, Wissing M, Potgieter JP, Temane M, Kruger A, Van Rooy S. Evaluation of the mental health continuum–short form (MHC–SF) in setswana-speaking South Africans. Clin Psychol Psychother. 2008;15(3):181–92. doi: 10.1002/cpp.572.
    1. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979;9(1):139–45. doi: 10.1017/S0033291700021644.
    1. ISAK., International Standards for Anthropometric Assessment. ISAK manual, International Society for the Advancement of Kinanthropometry (ISAK): Lower Hutt, New Zealand, 2011.
    1. Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, et al. Measurement of blood pressure in humans: A Scientific Statement from the American Heart Association. Hypertension. 2019;73(5):e35–e66. doi: 10.1161/HYP.0000000000000087.
    1. Levey AS, Stevens LA. Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J kidney Dis. 2010;55(4):622–7. doi: 10.1053/j.ajkd.2010.02.337.
    1. Fabian J, Kalyesubula R, Mkandawire J, Hansen CH, Nitsch D, Musenge E, et al. Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study. Lancet Glob Health. 2022;10(8):e1159–e69. doi: 10.1016/S2214-109X(22)00239-X.
    1. Johnson R, McNutt P, MacMahon S, Robson R. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin Chem. 1997;43(11):2183–84. doi: 10.1093/clinchem/43.11.2183.
    1. Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl (2011). 2013;3(1):1-150.
    1. Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New Creatinine- and cystatin C–Based equations to Estimate GFR without Race. N Eng J Med. 2021;385(19):1737–49. doi: 10.1056/NEJMoa2102953.
    1. Pottel H, Björk J, Courbebaisse M, Couzi L, Ebert N, Eriksen BO, et al. Development and validation of a modified full age Spectrum Creatinine-Based equation to Estimate glomerular filtration rate: a cross-sectional analysis of Pooled Data. Ann Intern Med. 2021;174(2):183–91. doi: 10.7326/M20-4366.
    1. Steubl D, Block M, Herbst V, Nockher WA, Schlumberger W, Satanovskij R, et al. Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney Disease patients. Med (Baltim) 2016;95(10):e3011–e. doi: 10.1097/MD.0000000000003011.
    1. Kim PS, Woods C, Dutcher L, Georgoff P, Rosenberg A, Mican JAM, et al. Increased prevalence of albuminuria in HIV-infected adults with diabetes. PLoS ONE. 2011 doi: 10.1371/journal.pone.0024610.
    1. Wensink GE, Schoffelen AF, Tempelman HA, Rookmaaker MB, Hoepelman AIM, Barth RE. Albuminuria is associated with traditional cardiovascular risk factors and viral load in HIV-infected patients in rural South Africa. PLoS ONE. 2015 doi: 10.1371/journal.pone.0136529.
    1. Alfano G, Cappelli G, Fontana F, Di Lullo L, Di Iorio B, Bellasi A, et al. Kidney disease in HIV infection. J Clin Med. 2019 doi: 10.3390/jcm8081254.
    1. Alves TP, Hulgan T, Wu P, Sterling TR, Stinnette SE, Rebeiro PF, et al. Race, kidney disease progression, and mortality risk in HIV-infected persons. Clin J Am Soc Nephrol. 2010;5(12):2269–75. doi: 10.2215/CJN.00520110.
    1. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis. 2012;59(5):628–35. doi: 10.1053/j.ajkd.2011.10.050.
    1. Campbell L, Ibrahim F, Fisher M, Holt S, Hendry B, Post F. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009;10(6):329–36. doi: 10.1111/j.1468-1293.2008.00691.x.
    1. Mihai S, Codrici E, Popescu ID, Enciu A-M, Albulescu L, Necula LG, et al. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res. 2018 doi: 10.1155/2018/2180373.
    1. Akchurin M, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1–3):84–92. doi: 10.1159/000368940.
    1. Zambrano-Galvan G, Rodríguez-Morán M, Simental-Mendía LE, Lazalde B, Reyes-Romero MA, Guerrero-Romero F. C-reactive protein is directly Associated with urinary albumin-to-creatinine ratio. Arch Med Res. 2011;42(6):451–6. doi: 10.1016/j.arcmed.2011.09.009.
    1. Sabanayagam C, Lee J, Shankar A, Lim SC, Wong TY, Tai ES. C-reactive protein and microalbuminuria in a multi-ethnic asian population. Nephrol Dial Transplant. 2010;25(4):1167–72. doi: 10.1093/ndt/gfp591.
    1. Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3(2):957–76. doi: 10.1002/cphy.c120028.
    1. Levin NW, Kotanko P, Eckardt K-U, Kasiske BL, Chazot C, Cheung AK et al. Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int. 2010;77(4):273 – 84.
    1. Lee JY, Park JT, Joo YS, Lee C, Yun H-R, Yoo T-H, et al. Association of blood pressure with the progression of CKD: findings from KNOW-CKD Study. Am J of Kidney Dis. 2021;78(2):236–45. doi: 10.1053/j.ajkd.2020.12.013.
    1. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387(10017):435–43. doi: 10.1016/S0140-6736(15)00805-3.
    1. Wu Z, Jin C, Vaidya A, Jin W, Huang Z, Wu S, et al. Longitudinal patterns of blood pressure, incident cardiovascular events, and all-cause mortality in normotensive diabetic people. Hypertension. 2016;68(1):71–7. doi: 10.1161/HYPERTENSIONAHA.116.07381.
    1. Matsha TE, Kengne AP, Masconi KL, Yako YY, Erasmus R. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans. BMC Genet. 2015 doi: 10.1186/s12863-015-0228-6.
    1. Ware LJ, Chidumwa G, Charlton K, Schutte AE, Kowal P. Predictors of hypertension awareness, treatment and control in South Africa: results from the WHO-SAGE population survey (Wave 2) J Hum Hypertens. 2019;33(2):157–66. doi: 10.1038/s41371-018-0125-3.
    1. Garland JS. Elevated body mass index as a risk factor for chronic kidney disease: current perspectives. Diabetes Metab Syndr Obes. 2014;7:347–55. doi: 10.2147/DMSO.S46674.
    1. Adeniyi AB, Laurence CE, Volmink JA, Davids MR. Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa. Clin Kidney J. 2017;10(3):363–9.
    1. Kalantar-Zadeh K, Rhee CM, Chou J, Ahmadi SF, Park J, Chen JL, et al. The obesity Paradox in kidney disease: how to reconcile it with obesity management. Kidney Int Rep. 2017;2(2):271–81. doi: 10.1016/j.ekir.2017.01.009.
    1. Cases A, Coll E. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int. 2005;68:87–S93. doi: 10.1111/j.1523-1755.2005.09916.x.
    1. Liu D-w, Jia W, Liu Z-s, Pei W, Cheng G-Y, Shi X-Z. Association between dyslipidemia and chronic kidney disease: a cross-sectional study in the middle-aged and elderly chinese population. Chin Med J. 2013;126(7):1207–12.
    1. Goldberg I, Krause I. The role of gender in chronic kidney disease. Eur Med J. 2016;1(2):58–64.
    1. Adjei DN, Stronks K, Adu D, Beune E, Meeks K, Smeeth L, et al. Chronic kidney disease burden among african migrants in three european countries and in urban and rural Ghana: the RODAM cross-sectional study. Nephrol Dial Transplant. 2018;33(10):1812–22. doi: 10.1093/ndt/gfx347.
    1. Stanifer JW, Maro V, Egger J, Karia F, Thielman N, Turner EL, et al. The epidemiology of chronic kidney disease in Northern Tanzania: a population-based survey. PLoS ONE. 2015;10(4):e0124506. doi: 10.1371/journal.pone.0124506.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться